Xueyi Weng

458 total citations
14 papers, 347 citations indexed

About

Xueyi Weng is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Xueyi Weng has authored 14 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Xueyi Weng's work include Extracellular vesicles in disease (5 papers), Cardiac Fibrosis and Remodeling (3 papers) and Phagocytosis and Immune Regulation (3 papers). Xueyi Weng is often cited by papers focused on Extracellular vesicles in disease (5 papers), Cardiac Fibrosis and Remodeling (3 papers) and Phagocytosis and Immune Regulation (3 papers). Xueyi Weng collaborates with scholars based in China, South Korea and Australia. Xueyi Weng's co-authors include Zheyong Huang, Yanan Song, Jinfeng Gao, Haipeng Tan, Zhiqing Pang, Jing Chen, Zhengmin Wang, Qiaozi Wang, Junbo Ge and Hongbo Yang and has published in prestigious journals such as Biomaterials, Chemical Engineering Journal and The American Journal of Medicine.

In The Last Decade

Xueyi Weng

14 papers receiving 344 citations

Peers

Xueyi Weng
Deborah D. Chin United States
Mengying Hou China
Juying Qian China
Asim M. Akhtar United Kingdom
Xiaodong Ning China
Catherine Y. Wang United States
Zhiliang Zhang China
Yuqiao Chang China
Evgeniya Vaskova United States
Deborah D. Chin United States
Xueyi Weng
Citations per year, relative to Xueyi Weng Xueyi Weng (= 1×) peers Deborah D. Chin

Countries citing papers authored by Xueyi Weng

Since Specialization
Citations

This map shows the geographic impact of Xueyi Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueyi Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueyi Weng more than expected).

Fields of papers citing papers by Xueyi Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueyi Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueyi Weng. The network helps show where Xueyi Weng may publish in the future.

Co-authorship network of co-authors of Xueyi Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Xueyi Weng. A scholar is included among the top collaborators of Xueyi Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueyi Weng. Xueyi Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Gao, Jinfeng, Xueyi Weng, Zhengmin Wang, et al.. (2025). Synergistic enhancement of efferocytosis and cholesterol efflux via macrophage biomimetic nanoparticle to attenuate atherosclerosis progression. Bioactive Materials. 55. 131–143. 1 indexed citations
2.
Tan, Haipeng, Weiyan Li, Zhiqing Pang, et al.. (2024). Genetically Engineered Macrophages Co‐Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion Injury. Advanced Healthcare Materials. 13(16). e2303267–e2303267. 15 indexed citations
3.
Gao, Jinfeng, Zhiqing Pang, Qiaozi Wang, et al.. (2024). Biomimetic Nano‐Degrader Based CD47‐SIRPα Immune Checkpoint Inhibition Promotes Macrophage Efferocytosis for Cardiac Repair. Advanced Science. 11(24). e2306388–e2306388. 9 indexed citations
4.
Yang, Hongbo, Lingfeng Luo, Zheyong Huang, et al.. (2024). Association Between Patient and System Delays and In-Hospital Mortality in Primary PCI for STEMI: Findings from a Large, Nationwide Inpatients Sample. The American Journal of Medicine. 137(12). 1227–1235.e8. 2 indexed citations
5.
6.
Li, Qiyu, Zheyong Huang, Zhiqing Pang, et al.. (2022). Targeted delivery of platelet membrane modified extracellular vesicles into atherosclerotic plaque to regress atherosclerosis. Chemical Engineering Journal. 452. 138992–138992. 27 indexed citations
7.
Chen, Jing, Yanan Song, Qiaozi Wang, et al.. (2022). Targeted neutrophil-mimetic liposomes promote cardiac repair by adsorbing proinflammatory cytokines and regulating the immune microenvironment. Journal of Nanobiotechnology. 20(1). 218–218. 36 indexed citations
8.
Li, Qiyu, Zheyong Huang, Qiaozi Wang, et al.. (2022). Targeted immunomodulation therapy for cardiac repair by platelet membrane engineering extracellular vesicles via hitching peripheral monocytes. Biomaterials. 284. 121529–121529. 95 indexed citations
9.
Weng, Xueyi, Haipeng Tan, Zheyong Huang, et al.. (2022). Targeted delivery and ROS-responsive release of Resolvin D1 by platelet chimeric liposome ameliorates myocardial ischemia–reperfusion injury. Journal of Nanobiotechnology. 20(1). 454–454. 29 indexed citations
10.
Yang, Hongbo, Lingfeng Luo, Jiatian Cao, et al.. (2022). The Peripandemic Impact of the First Wave of the COVID-19 Pandemic on Management and Prognosis of ST-Segment Elevation Myocardial Infarction in China. Journal of Clinical Medicine. 11(24). 7290–7290. 1 indexed citations
11.
Gao, Jinfeng, Yanan Song, Qiaozi Wang, et al.. (2022). Precisely co-delivery of protein and ROS scavenger with platesomes for enhanced endothelial barrier preservation against myocardial ischemia reperfusion injury. Chemical Engineering Journal. 446. 136960–136960. 19 indexed citations
12.
Yang, Hongbo, Yanan Song, Jiatian Cao, et al.. (2021). Double kissing inflation outside the stent secures the patency of small side branch without rewiring. BMC Cardiovascular Disorders. 21(1). 232–232. 4 indexed citations
13.
Tan, Haipeng, Yanan Song, Jing Chen, et al.. (2021). Platelet‐Like Fusogenic Liposome‐Mediated Targeting Delivery of miR‐21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia‐Reperfusion Injury. Advanced Science. 8(15). e2100787–e2100787. 100 indexed citations
14.
Weng, Xueyi, et al.. (2001). Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.. PubMed. 73(1). 1–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deborah D. Chin Breakdown of academic impact, for papers by Mengying Hou Breakdown of academic impact, for papers by Juying Qian Breakdown of academic impact, for papers by Asim M. Akhtar Breakdown of academic impact, for papers by Xiaodong Ning Breakdown of academic impact, for papers by Catherine Y. Wang Breakdown of academic impact, for papers by Zhiliang Zhang Breakdown of academic impact, for papers by Yuqiao Chang Breakdown of academic impact, for papers by Evgeniya Vaskova
Rankless by CCL
2026